Literature DB >> 26521773

Chemical Structure Similarity Search for Ligand-based Virtual Screening: Methods and Computational Resources.

Xin Yan, Chenzhong Liao, Zhihong Liu, Arnold T Hagler, Qiong Gu1, Jun Xu.   

Abstract

For many years the assumption that "Chemical compounds with similar structures may have similar activities" has been a foundation for lead identification. The similarity can be computed based upon topological, steric, electronic, and/or physical properties. The chemical structure similarity search differs from the chemical substructure search in that the former requires assessment of the properties of each compound and thus no filter can be applied for skipping structures before they are assessed to accelerate the computation. The latter can be accelerated by pre-screening compounds and omitting those that miss one (or more) specified fragments from the query. Moreover, three-dimensional similarity search requires superimposing many conformation pairs for each compound in the library. This makes 3-D similarity search algorithms time-consuming, and in general requires high performance computing (HPC) resources. This review will summarize recent progress in the techniques for HPC-supported two and three-dimensional chemical structure similarity search algorithms, and their applications in ligand-based virtual screening.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26521773     DOI: 10.2174/1389450116666151102095555

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  15 in total

Review 1.  Systems Pharmacology in Small Molecular Drug Discovery.

Authors:  Wei Zhou; Yonghua Wang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-02-18       Impact factor: 5.923

2.  Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways.

Authors:  Hee-Don Chae; Nick Cox; Gary V Dahl; Norman J Lacayo; Kara L Davis; Samanta Capolicchio; Mark Smith; Kathleen M Sakamoto
Journal:  Oncotarget       Date:  2017-12-31

3.  Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships.

Authors:  Shaodan Chen; Xiangmin Li; Tianqiao Yong; Zhanggen Wang; Jiyan Su; Chunwei Jiao; Yizhen Xie; Burton B Yang
Journal:  Oncotarget       Date:  2017-02-07

4.  Assessment of a Single Decoupling Alchemical Approach for the Calculation of the Absolute Binding Free Energies of Protein-Peptide Complexes.

Authors:  Denise Kilburg; Emilio Gallicchio
Journal:  Front Mol Biosci       Date:  2018-03-08

5.  OptiPharm: An evolutionary algorithm to compare shape similarity.

Authors:  S Puertas-Martín; J L Redondo; P M Ortigosa; H Pérez-Sánchez
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 6.  Thymus Regeneration and Future Challenges.

Authors:  Valentin P Shichkin; Mariastefania Antica
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

7.  Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual Screening.

Authors:  Jean-Paul Ebejer; Paul W Finn; Wing Ki Wong; Charlotte M Deane; Garrett M Morris
Journal:  J Chem Inf Model       Date:  2019-06-04       Impact factor: 4.956

Review 8.  Mimicking Strategy for Protein-Protein Interaction Inhibitor Discovery by Virtual Screening.

Authors:  Ke-Jia Wu; Pui-Man Lei; Hao Liu; Chun Wu; Chung-Hang Leung; Dik-Lung Ma
Journal:  Molecules       Date:  2019-12-04       Impact factor: 4.411

Review 9.  Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators.

Authors:  Lucía Pérez-Regidor; Malik Zarioh; Laura Ortega; Sonsoles Martín-Santamaría
Journal:  Int J Mol Sci       Date:  2016-09-09       Impact factor: 5.923

10.  An integrated strategy for identifying new targets and inferring the mechanism of action: taking rhein as an example.

Authors:  Hao Sun; Yiting Shen; Guangwen Luo; Yuepiao Cai; Zheng Xiang
Journal:  BMC Bioinformatics       Date:  2018-09-06       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.